Search research articles
Contact Us
Filters
Showing results (321-330 of 348) with videos related to
Page
of 35
Sort By:
Cancer Immunology, Immunotherapy : CII
|
June 9, 2023
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
Colt A Egelston, Weihua Guo, Susan E Yost, et al.
Gynecologic Oncology
|
January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer
Mihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 4, 2021
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer
Yuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cancer Research Communications
|
July 25, 2022
Influence of germline <i>BRCA</i> genotype on the survival of patients with triple-negative breast cancer
Cynthia Villarreal-Garza, Ana S Ferrigno, Alejandro Aranda-Gutierrez, et al.
BMC Nephrology
|
October 25, 2023
UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE
Alistair J Roddick, Alexa Wonnacott, David Webb, et al.
Antioxidants (Basel, Switzerland)
|
April 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate
Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
November 11, 1999
A multi-institutional study of factors associated with fetal death in injured pregnant patients
F B Rogers, G S Rozycki, T M Osler, et al.
Antioxidants (Basel, Switzerland)
|
December 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. <i>Antioxidants</i> 2025, <i>14</i>, 345
Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
September 26, 2022
First-In-Human Pilot PET Immunoimaging Study of <sup>64</sup>Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers
Jeffrey Y C Wong, David M Yamauchi, Vikram Adhikarla, et al.
Kidney International Reports
|
October 27, 2025
Association of British Clinical Diabetologists and UK Kidney Association Joint Clinical Practice Guidelines for the Pharmacological Management of Hyperglycemia in Adults With Type 2 Diabetes Mellitus and CKD
Janaka Karalliedde, Kieran McCafferty, Peter Winocour, et al.
Page
of 35
Search research articles
Search
Showing results (321-330 of 348) with videos related to
Sort By:
Page
of 35
Cancer Immunology, Immunotherapy : CII
|
June 9, 2023
Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer
Colt A Egelston, Weihua Guo, Susan E Yost, et al.
Gynecologic Oncology
|
January 23, 2024
A phase I study of Mirvetuximab Soravtansine and gemcitabine in patients with FRα-positive recurrent ovarian, primary peritoneal, fallopian tube, or endometrial cancer, or triple negative breast cancer
Mihaela C Cristea, Daphne Stewart, Timothy Synold, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 4, 2021
Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer
Yuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Cancer Research Communications
|
July 25, 2022
Influence of germline <i>BRCA</i> genotype on the survival of patients with triple-negative breast cancer
Cynthia Villarreal-Garza, Ana S Ferrigno, Alejandro Aranda-Gutierrez, et al.
BMC Nephrology
|
October 25, 2023
UK Kidney Association Clinical Practice Guideline: Sodium-Glucose Co-transporter-2 (SGLT-2) Inhibition in Adults with Kidney Disease 2023 UPDATE
Alistair J Roddick, Alexa Wonnacott, David Webb, et al.
Antioxidants (Basel, Switzerland)
|
April 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate
Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
November 11, 1999
A multi-institutional study of factors associated with fetal death in injured pregnant patients
F B Rogers, G S Rozycki, T M Osler, et al.
Antioxidants (Basel, Switzerland)
|
December 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. <i>Antioxidants</i> 2025, <i>14</i>, 345
Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Cancer Biotherapy & Radiopharmaceuticals
|
September 26, 2022
First-In-Human Pilot PET Immunoimaging Study of <sup>64</sup>Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers
Jeffrey Y C Wong, David M Yamauchi, Vikram Adhikarla, et al.
Kidney International Reports
|
October 27, 2025
Association of British Clinical Diabetologists and UK Kidney Association Joint Clinical Practice Guidelines for the Pharmacological Management of Hyperglycemia in Adults With Type 2 Diabetes Mellitus and CKD
Janaka Karalliedde, Kieran McCafferty, Peter Winocour, et al.
Page
of 35